Benzinga | May 12, 2021 08:01AM EDT

Desktop Health Receives FDA Clearance For Flexcera For Next Generation 3D Printed Dentures

Proprietary Resin Technology for Dental Prosthetics Delivers Superior Strength, Aesthetics and Function for Patients

* Developed, tested, and selected from more than 200 formulations

* Unique long-chain chemistry formulated and optimized for 3D printing

* Pioneers a same-day digital denture solution with three times the toughness of competitor denture material and lifelike tooth translucency

Desktop Health, recently launched by Desktop Metal, Inc. (NYSE:DM) and committed to developing 3D printing and biofabrication solutions for personalized medicine, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of FlexceraTM Base, a proprietary resin for use in 3D fabrication of high-quality dental prosthetics. Flexcera Base along with the new FlexceraTM Smile are Desktop Health's first formulated and optimized digital dental solutions.